Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0043167 (
pertussis
)
19,595
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Filamentous hemagglutinin adhesin (FHA) is important for the adherence of Bordetella
pertussis
to the host ciliary epithelial cells of the respiratory tract. Several binding domains have been characterized in the FHA molecule. For example, an putative heparin-binding domain of FHA was previously located in the FHA(442-863) region. In this work, the
HEP
fragment, corresponding to FHA(430-873) was amplified by PCR and subcloned in an Escherichia coli expression plasmid. Purified recombinant
HEP
was used to produce polyclonal antibodies in mice that were able to recognize
HEP
and FHA in ELISA and in Western-blot assays. Although recombinant
HEP
displayed low ability to bind heparin and no hemagglutination activity, the anti-
HEP
antibodies were able to inhibit FHA mediated hemagglutination activity in goose erythrocytes. These results indicate that other amino acid residues that are not present in the FHA(430-873) fragment may be necessary for heparin binding. Further studies to address the immunogenic response against
HEP
are also required.
...
PMID:Antibodies produced against a fragment of filamentous haemagglutinin (FHA) of Bordetella pertussis are able to inhibit hemagglutination induced by the whole adhesin. 1550 Sep 77
Filamentous haemagglutinin adhesin (FHA) is an important virulence factor from Bordetella
pertussis
related to the adhesion and spread of the bacteria through the respiratory tract. Three distinct domains have been characterized in mature FHA, and among them, the FHA(442-863) fragment was suggested to be responsible for the heparin-binding activity. In this study, we cloned the gene encoding the
HEP
fragment (FHA(430-873)) in a Lactobacillus casei-inducible expression vector based on the lactose operon. The recombinant bacteria, transformed with the resulting construct (L. casei-
HEP
), were able to express the heterologous protein depending on the sugar added to the culture. Subcutaneous inoculation of L. casei-
HEP
in Balb/C mice, using the cholera toxin B subunit as adjuvant, induced systemic anti-
HEP
antibodies that were able to inhibit in vitro erythrocyte haemagglutination induced by FHA. This is the first example of a B.
pertussis
antigen produced in lactic acid bacteria and opens new perspectives for alternative vaccine strategies against whooping cough.
...
PMID:Haemagglutination induced by Bordetella pertussis filamentous haemagglutinin adhesin (FHA) is inhibited by antibodies produced against FHA(430-873) fragment expressed in Lactobacillus casei. 1710 3